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Evaluation of Metabolic Syndrome in Patients with Chronic Low 
Back Pain: Using the Fourth Korea National Health and Nutrition 
Examination Survey Data
Jae Yong Ha*
Department of Rehabilitation Medicine, Seoul Medical Center, Seoul, Korea
The aim of this study was to investigate the frequency of the metabolic syndrome in 
patients with chronic lower back pain in Korea and to evaluate the differences in clinical 
characteristics in chronic lower back pain patients with and without metabolic 
syndrome. This was a cross-sectional study using data from the fourth Korea National 
Health and Nutrition Examination Survey (KNHANES IV) 2008. The sample consisted 
of 1085 participants with chronic lower back pain. The diagnosis of metabolic syndrome 
was made according to the criteria of the National Cholesterol Education Program 
Adult Treatment Panel III (NCEP-ATP III) and the Korean Society for the Study of 
Obesity. The prevalence of metabolic syndrome among chronic lower back pain patients 
was 36.2% (30.2% male, 38.6% female). According to our results, female sex, advanced 
age, and high BMI were risk factors for metabolic syndrome. These results from a repre-
sentative sample show that metabolic syndrome is common in chronic lower back pain 
patients in Korea. Clinicians managing chronic lower back pain should consider the 
risk factors for metabolic syndrome.
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INTRODUCTION
Metabolic syndrome is a complicated metabolic disease 
that includes abdominal obesity, hypertension, insulin re-
sistance or glucose intolerance, and dyslipoproteinemia.
1 
The prevalence of this syndrome has increased with obesity 
worldwide.
2
Metabolic syndrome is closely related to several other 
diseases linked to obesity, and low back pain is one of those. 
In previous studies, obesity was a direct risk factor of low 
back pain,
3-5 and degenerative arthritis due to obesity was 
shown to reduce physical activities indirectly, causing an 
increase in serum lipid concentrations leading to arterio-
sclerosis, and to cause low back pain.
6 For these reasons, 
evaluation of metabolic syndrome is important in the treat-
ment of patients with chronic low back pain. Although the 
relationship between metabolic syndrome and other dis-
eases, such as cardiovascular diseases,
7 diabetes,
8 bipolar 
disorder,
9 reflux esophagitis,
10 ischemic stroke,
11 poly-
cystic ovary syndrome,
12 and hypogonadism,
13 has been 
studied, the relationship between metabolic syndrome and 
chronic low back pain has rarely been studied inside and 
outside the country.
The aim of this study was therefore to investigate the 
prevalence of metabolic syndrome in patients having 
chronic low back pain and to evaluate the differences be-
tween patients with or without metabolic syndrome. The 
study was based on the results and surveys of the fourth 
session of the Korea National Health and Nutrition Exami-
nation Survey (KNHANES), which was performed in a 
household sample selected from the population in Korea in 
2008.
MATERIALS AND METHODS
1. Subjects
The study population was selected from among a total 
sample population of 9744 who participated in a health in-
terview during the fourth session of KNHANES in the sec-
ond year (Jan 2008-Dec 2008). In this study, a patient hav-161
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TABLE 1. Characteristics of the study population
Characteristics Men Women p value
No. of subjects
Age (years)
Body mass index (kg/m
2)
Waist circumference (cm)
Systolic blood pressure (SBP, mmHg)
Diastolic blood pressure (DBP, mmHg)
Fasting plasma glucose (mg/dl)
Total cholesterol (mg/dl)
Triglyceride (mg/dl)
HDL cholesterol (mg/dl)
Hypertension (%)
Diabetes (%)
Metabolic syndrome (MS) (%)
305
58.4 (16.3) 
23.2 (2.8)
84.1 (8.5)
118.8 (16.4)
73.8 (10.3)
98.7 (19.8)
179.5 (34.0)
155.7 (128.0)
44.3 (10.2) 
38.7
37.0
30.2
780
59.2 (16.1) 
24.0 (3.4)
82.8 (10.2) 
120.1 (19.3)
73.2 (11.0)
99.1 (29.0)
194.2 (36.7)
133.4 (93.4)
47.7 (11.0) 
46.7
33.7
38.6
0.471
＜0.001
0.042
0.234
0.387
0.840
＜0.001
0.007
＜0.001
0.017
0.312
0.009
HDL: high-density lipoprotein.
ing chronic low back pain was defined as one who replied 
that his or her back was ‘painful more than three months 
for a recent year’ on the item about low back pain. A total 
of 1085 subjects (11.1%) were finally selected.
2. Methods
Metabolic syndrome was diagnosed when the patient 
had three of five items according to the recommendation 
of the U.S. National Cholesterol Education Program Adult 
Treatment Panel III (NCEP-ATP III)
14 and the Korean 
Society for the Study of Obesity
15 as follows:
i) Waist circumference of more than 90 cm (male) or 85 
cm (female)
ii) Systolic blood pressure more than 130 mmHg or dia-
stolic blood pressure more than 85 mmHg or a re-
sponse of ‘yes’ for a hypertension diagnosis
iii) Fasting plasma glucose of more than 100 mg/dl or a 
response of ‘yes’ for a diabetes diagnosis
iv) Triglycerides more than 150 mg/dl
v) HDL cholesterol less than 40 mg/dl (male) or 50 mg/dl 
(female)
In a physical examination, waist measurement was per-
formed in the narrowest part between the lower thorax and 
the iliac crest. For measuring BMI, the height and weight 
were measured after the patient took off his or her shoes 
and while wearing a thin gown. Blood pressure was meas-
ured three times in 5-minute intervals and the second and 
third values were added and then divided in half. Fasting 
plasma glucose was measured by sampling the blood in the 
morning after the patient had fasted for 12 hours. Various 
clinical tests were performed by the two institutes and dif-
ferent values for HDL cholesterol owing to different analy-
sis methods and equipment between the two institutes 
were used.
On items about regular exercise among the questions 
concerning life habits, intense physical activities meant 
more than 20 minutes three times weekly and moderate 
physical activities or walking meant more than 30 minutes 
five times per week. Items about smoking consisted of to 
smoke, to quit smoking, and not applicable. Drinking was 
classified into less than once a month, 1-4 times a month, 
and more than twice a week.
3. Statistical analysis
SAS version 9.2 was used for statistical analysis. The sig-
nificance level was a p-value ＜0.05. For each factor, con-
tinuous variables were analyzed by t-test and categorical 
variables were analyzed by chi-square test.
RESULTS
1. Features of patients having chronic low back pain (Table 1)
Among the entire subjects, 1,085 subjects reported chro-
nic low back pain, including 305 males and 780 females. 
The average age was 58.4±16.3 years in the males and 
59.2±16.1 years in the females. In addition, the prevalence 
of hypertension was 38.7% in the males and 46.7% in the 
females; thus, women showed a higher prevalence. On the 
contrary, the prevalence of diabetes was 37.0% in the males 
and 33.7% in the females; thus, men showed higher pre-
valence. The rate of subjects having metabolic syndrome 
was 30.2% in the males and 38.6% in the females. It was 
significantly higher in females.
2. Comparison by metabolic syndrome in male patients 
having chronic low back pain (Table 2)
Among 305 male patients having chronic low back pain, 
92 patients (30.2%) had metabolic syndrome. The average 
was 61.5±13.1 years in the patients having metabolic syn-
drome, which was significantly higher than the age of 57.0± 
17.4 years of the patients without metabolic syndrome. 
BMI, which showed obesity, was 22.5±2.7 in the patients 
without metabolic syndrome, but it was higher, 24.8±2.5, 
in the patients having metabolic syndrome. Waist mea-
surement, systolic and diastolic blood pressure, fasting 
plasma glucose, triglycerides, and total cholesterol were 
significantly higher in the patients having metabolic syn-
drome. HDL was significantly lower in those patients. The 162
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TABLE 2. Differences in the clinical characteristics of patients with and without metabolic syndrome (men)
Characteristics
Patients with 
metabolic syndrome 
Patients without 
metabolic syndrome 
p value
No. of subjects 92 213
Age (years)   61.5 (13.1) 57.0 (17.4) 0.014
Body mass index (kg/m
2) 24.8 (2.5) 22.5 (2.7) ＜0.001
Waist circumference (cm) 90.2 (6.5) 81.4 (7.9) ＜0.001
Systolic blood pressure (SBP, mmHg) 124.9 (13.9) 116.1 (16.6) ＜0.001
Diastolic blood pressure (DBP, mmHg) 78.3 (9.9) 71.9 (10.0) ＜0.001
Fasting plasma glucose (mg/dl) 108.9 (23.7) 94.1 (15.8) ＜0.001
Total cholesterol (mg/dl) 186.6 (35.5) 176.3 (32.9) 0.016
Triglyceride (mg/dl)   230.8 (167.3) 121.8 (86.9) ＜0.001
HDL cholesterol (mg/dl) 38.6 (7.5) 46.9 (10.2) ＜0.001
Hypertension (%) 66.3 26.8 ＜0.001
Diabetes (%) 71.7 21.5 ＜0.001
Regular exercise (%) 63.0 67.9 0.408
Smoking status  Current smoker 28 91
Ex-smoker 50 86 0.069
Nonsmoker 14 35
Drinking frequency ＜1 time per month 34 91
1-4 times per month 20 56 0.110
≥2 times per week 31 47
HDL: high-density lipoprotein.
TABLE 3. Differences in the clinical characteristics of patients with and without metabolic syndrome (women)
Characteristics
Patients with 
metabolic syndrome 
Patients without 
metabolic syndrome 
p value
No. of subjects 301 479
Age (years) 65.2 (10.9) 55.4 (17.6) ＜0.001
Body mass index (kg/m
2) 25.9 (3.1) 22.8 (3.0) ＜0.001
Waist circumference (cm) 89.4 (8.2) 78.6 (9.0) ＜0.001
Systolic blood pressure (SBP, mmHg) 128.9 (17.0) 114.6 (18.6) ＜0.001
Diastolic blood pressure (DBP, mmHg) 76.7 (10.4) 71.0 (10.9) ＜0.001
Fasting plasma glucose (mg/dl) 110.5 (41.7) 91.3 (9.6) ＜0.001
Total cholesterol (mg/dl) 202.4 (37.2) 188.6 (32.3) ＜0.001
Triglyceride (mg/dl) 183.9 (112.5) 99.3 (56.5) ＜0.001
HDL cholesterol (mg/dl) 42.6 (8.3) 51.2 (11.3) ＜0.001
Hypertension (%) 76.4 28.0 ＜0.001
Diabetes (%) 62.8 14.1 ＜0.001
Regular exercise (%) 58.7 62.8 0.254
Smoking status  Current smoker 12 31
Ex-smoker 12 33 0.068
Nonsmoker 277 415
Drinking frequency ＜1 time per month 17 32
1-4 times per month 38 117 0.003
≥2 times per week 137 201
HDL: high-density lipoprotein.
prevalence of hypertension and diabetes was 66.3% and 
71.7%, respectively, in the patients having metabolic syn-
drome. Those were vastly higher than the 26.8% and 21.5% 
in the patients without metabolic syndrome. In the com-
parison of life habits, exercise, smoking, and drinking fre-
quency were not significantly different from the frequen-
cies in the group without metabolic syndrome.
3. Comparison by metabolic syndrome in female patients 
having chronic low back pain (Table 3)
In 780 female patients having chronic low back pain, 301 
patients (38.6%) had metabolic syndrome and the rate was 
higher than in males. The average age was 65.2±10.9 years 
in the patients having metabolic syndrome, which was sig-
nificantly higher than the age of 55.4±17.6 years of the pa-163
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tients without metabolic syndrome. BMI was 25.9±3.1 in 
the patients having metabolic syndrome, which was higher 
than the 22.8±3.0 of the patients without metabolic syn-
drome, the same as for the males. Waist measurement, sys-
tolic and diastolic blood pressure, fasting plasma glucose, 
triglycerides, and total cholesterol were significantly higher 
in the patients having metabolic syndrome. HDL was also 
significantly lower in those patients. The prevalence of hy-
pertension and diabetes was 76.4% and 62.8%, respectively, 
in the patients having metabolic syndrome, which was 
higher than in the patients without metabolic syndrome. 
On items concerning life habits, exercise and smoking were 
not significantly different from the habits of the group with-
out metabolic syndrome, but drinking frequency was signi-
ficantly higher in the patients having metabolic syndrome.
DISCUSSION
The prevalence of metabolic syndrome in patients having 
chronic low back pain was 30.2% in males and 38.6% in 
females. This was higher than the 21.6% (1998) and 21.4% 
(2001)
16 according to the application of the APC-WC stand-
ards in the nation in the past. The rate of patients having 
metabolic syndrome was high among females, which agrees 
with previous results in other Asian areas.
17,18
In patients having chronic low back pain, when the age 
of the two groups with or without metabolic syndrome was 
compared, the average age of the patients having metabolic 
syndrome was higher. The difference in females was parti-
cularly large, which might have been caused by the increased 
prevalence of abdominal obesity with weight increases rela-
ted to hormonal changes after menopause, which might in-
crease the prevalence of metabolic syndrome.
14
BMI, waist measurement, blood pressure, fasting plasma 
glucose, total cholesterol, and triglycerides were higher 
and HDL was lower in the patients having metabolic syn-
drome. This result could be predicted according to the diag-
nostic standards for metabolic syndrome. In addition, the 
prevalence of hypertension and diabetes was higher in the 
patients having metabolic syndrome. 
Factors related to life habits, such as regular exercise, 
smoking, and drinking frequency, were compared. Drin-
king frequency and the prevalence of metabolic syndrome 
were significantly higher in the female group with chronic 
low back pain but other factors were not related. This result 
partly agrees with previous studies of the relationship be-
tween drinking habits and the prevalence of metabolic 
syndrome.
19
Metabolic syndrome occurs with risk factors for several 
cardiovascular diseases owing to abdominal obesity and in-
sulin resistance. An increase of adipose tissues causes 
blood free fatty acids to rise and to express insulin resist-
ance in insulin-sensitive organs, such as liver, muscle, and 
pancreas.
1,20 This is closely related to TNF-α, which is an 
inflammatory adipokine. In addition, TNF-α is known to 
be important in patients with low back pain,
21,22 and it was 
reported that TNF-α blockers have been used for the treat-
ment of lower back pain.
23,24 Therefore, the relationship be-
tween low back pain and metabolic syndrome needs to be 
studied.
Some limitations were found in this study. First, it was 
impossible to determine cause and effect in the interpre-
tation of data because this was a cross-sectional study. Se-
cond, self-recording methods were used to define patients 
with chronic low back pain, which thus might not be accu-
rate. Third, the prevalence of metabolic syndrome in patients 
with chronic low back pain in our study seemed to be higher 
than the actual incidence because of the mean age of the 
subjects. Fourth, a univariate analysis was provided to 
evaluate the factors associated with metabolic syndrome 
instead of a multivariate analysis. However, this study was 
performed in a nation as a sample, so this result could be 
representative despite the limitations. In addition, this 
study could indicate various views by which to approach 
low back pain patients concerning the relationship be-
tween low back pain and metabolic syndrome.
According to this study, the prevalence of metabolic syn-
drome was higher in patients having chronic low back pain 
who were female, who were of an advanced age, and who 
had a high BMI. Hereafter, in the treatment of patients 
having chronic low back pain, factors related to metabolic 
syndrome should be evaluated.
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